drugset / Trial / NCT03413618
Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
RandomizedParallel-groupSingle-blindTreatment
Summary
The randomized clinical study aimed to assess the efficacy and safety of standard anticoagulation with rivaroxaban in combination with diosmin compared to the isolated use of standard rivaroxaban for prolonged therapy of acute femoro-popliteal deep vein thrombosis reflected the speed of deep vein recanalization and incidence of post-thrombotic syndrome.
Timeline
- Start
- 2017-12-20
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diosmin | Small molecule | 600 mg | — |
| Background | Rivaroxaban | Other / unclassified | 20 mg | — |